Prohledat tento blog

09.10.11

Practice Changing: High-Dose Radiation Not Superior in NSCLC

Non-small cell lung carcinomaImage via WikipediaPractice Changing: High-Dose Radiation Not Superior in NSCLC


A landmark trial in nonsmall-cell lung cancer (NSCLC) has found that high-dose conformal radiotherapy (74 Gy) did not improve survival, compared with the standard dose (60 Gy), in patients with unresectable stage III disease.
In fact, median overall survival was better with the standard dose than with the high dose...........


Enhanced by Zemanta

Peritoneal cancer index

Poznámky používá se k hodnocení rozsahu postižení peritoneální dutiny nádorem COLOPEC klinická studie kolorektální karcino...